ChatDocto
Find a doctor
White scored tablet

VIBRAMYCINE N 100 mg

Doxycycline · scored tablets

B/10Oral use
5,480 DTRecorded public price · B/10
See all pack prices
Strength100 mg
Therapeutic classANTIINFECTIEUX GENERAUX A USAGE SYSTEMIQUE
ATC codeJ01AA02

About this medicine

VIBRAMYCINE N 100 mg scored tablets is listed in Tunisia's medicine catalog under the active ingredient Doxycycline. This page brings together its recorded pack formats, prices and CNAM coverage information.

What is this medicine used for?

Review pending

A reviewed explanation of uses is not yet published for this medicine in this language. Ask a pharmacist for the leaflet for your exact product.

What side effects should I know about?

Review pending

A reviewed side-effect guide is not yet published for this medicine in this language. This does not mean that the medicine has no side effects. Read your product leaflet or ask a pharmacist.

Price by pack

Compare the recorded price for each exact pack. A catalog entry does not confirm pharmacy stock.

  • Pack · B/10

    10 units in this pack

    Recorded public price5,480 DT
    AMM No.
    9243021
    CNAM code
    306068
    CNAM reference amount
    4,070 DT

    Price source: CNAM — Liste des médicaments remboursables · 2026-08-04

    Source recorded: August 23, 2026

    Price effective date not provided

This reference amount is not a guaranteed refund or a personal out-of-pocket estimate. Your coverage conditions must be confirmed separately.

Medicine details

Dosage formscored tablets
Route of administrationOral use
LaboratoryPFIZER TUNISIE
OriginOriginator
ScheduleA
ATC codeJ01AA02 — Doxycycline
Therapeutic classANTIINFECTIEUX GENERAUX A USAGE SYSTEMIQUE

Medicines with matching catalog characteristics

These entries match the recorded ingredient, strength, form and route. This does not establish that they can replace your medicine; confirm any change with a pharmacist.

DOXY 100 mgComprimés sécablesGALPHARMA · B/20
Recorded public price8,150 DT

Price source: CNAM — Liste des médicaments remboursables · 2026-08-04

Source recorded: August 23, 2026